Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

Top 10 Oil-producing Countries (Updated 2024)

A State-by-State Guide to Cannabis in Australia (Updated 2024)

What Was the Highest Price for Gold? (Updated 2024)

Investing in Graphene Companies (Updated 2024)

7 Biggest Lithium-mining Companies in 2024

Hydrogen Stocks: 9 Biggest Companies in 2024

Don Durrett: Gold, Silver Price Targets, Plus When to Buy Gold Stocks

Top 10 Copper-producing Companies (Updated 2024)

Trending Press Releases

Allup Strengthens its Board with Mine and Finance Delivery Expertise with Mr Peter Secker and Simon Finnis Joining the Company Effective Immediately

Allup Acquires 100% of McLaren Valuable Heavy Mineral Sands Project, West Eucla Basin, WA and Conducts Placement

Significant New Uranium Discovery at Big Lake Uranium Project, South Australia

Sarama Resources Advances Acquisition of Gold Project in Western Australia

TNC Accelerates Mining Activities at Wallace North, QLD

Elixir Energy Limited (ASX: EXR) – Trading Halt

More Press Releases
Trending Companies

Black Swan Graphene

SWAN:CC

Silver Crown Royalties

SCRI:CC

Flynn Gold

FG1:AU

True North Copper

TNC:AU
More Companies
Trending Reports

Investing in Physical Gold: Practical Insights and Strategies for Retail Investors

Precious Metals Outlook

2024 Copper Outlook Report

2024 Gold Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Nektar Therapeutics

NASDAQ:NKTR

Nektar Therapeutics is a biopharmaceutical company.

Press Releases
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India.

Interactive Chart

×